United States High Potency API Market Report 2017

In this report, the United States High Potency API market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of High Potency API in these regions, from 2012 to 2022 (forecast).

United States High Potency API market competition by top manufacturers/players, with High Potency API sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Novartis International
Sanofi
Boehringer Ingelheim
Bristol-Myers Squibb
Teva Pharmaceutical
Eli Lilly and Company
GlaxoSmithKline
Merck & Co
AbbVie
Johnson & Johnson
Bayer
Mylan

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Synthetic HPAPIs
Biotech HPAPIs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of High Potency API for each application, including
Oncology
Hormonal Disorders
Glaucoma
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States High Potency API Market Report 2017
1 High Potency API Overview
1.1 Product Overview and Scope of High Potency API
1.2 Classification of High Potency API by Product Category
1.2.1 United States High Potency API Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States High Potency API Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Synthetic HPAPIs
1.2.4 Biotech HPAPIs
1.3 United States High Potency API Market by Application/End Users
1.3.1 United States High Potency API Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Oncology
1.3.3 Hormonal Disorders
1.3.4 Glaucoma
1.3.5 Other
1.4 United States High Potency API Market by Region
1.4.1 United States High Potency API Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West High Potency API Status and Prospect (2012-2022)
1.4.3 Southwest High Potency API Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic High Potency API Status and Prospect (2012-2022)
1.4.5 New England High Potency API Status and Prospect (2012-2022)
1.4.6 The South High Potency API Status and Prospect (2012-2022)
1.4.7 The Midwest High Potency API Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of High Potency API (2012-2022)
1.5.1 United States High Potency API Sales and Growth Rate (2012-2022)
1.5.2 United States High Potency API Revenue and Growth Rate (2012-2022)

2 United States High Potency API Market Competition by Players/Suppliers
2.1 United States High Potency API Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States High Potency API Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States High Potency API Average Price by Players/Suppliers (2012-2017)
2.4 United States High Potency API Market Competitive Situation and Trends
2.4.1 United States High Potency API Market Concentration Rate
2.4.2 United States High Potency API Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers High Potency API Manufacturing Base Distribution, Sales Area, Product Type

3 United States High Potency API Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States High Potency API Sales and Market Share by Region (2012-2017)
3.2 United States High Potency API Revenue and Market Share by Region (2012-2017)
3.3 United States High Potency API Price by Region (2012-2017)

4 United States High Potency API Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States High Potency API Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States High Potency API Revenue and Market Share by Type (2012-2017)
4.3 United States High Potency API Price by Type (2012-2017)
4.4 United States High Potency API Sales Growth Rate by Type (2012-2017)

5 United States High Potency API Sales (Volume) by Application (2012-2017)
5.1 United States High Potency API Sales and Market Share by Application (2012-2017)
5.2 United States High Potency API Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States High Potency API Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 High Potency API Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis International
6.2.2 High Potency API Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis International High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Sanofi
6.3.2 High Potency API Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim
6.4.2 High Potency API Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Boehringer Ingelheim High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
6.5.2 High Potency API Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bristol-Myers Squibb High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Teva Pharmaceutical
6.6.2 High Potency API Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Teva Pharmaceutical High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Eli Lilly and Company
6.7.2 High Potency API Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Eli Lilly and Company High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
6.8.2 High Potency API Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 GlaxoSmithKline High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Merck & Co
6.9.2 High Potency API Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck & Co High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 AbbVie
6.10.2 High Potency API Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 AbbVie High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Johnson & Johnson
6.12 Bayer
6.13 Mylan

7 High Potency API Manufacturing Cost Analysis
7.1 High Potency API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of High Potency API

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 High Potency API Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of High Potency API Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States High Potency API Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States High Potency API Sales Volume, Revenue Forecast (2017-2022)
11.2 United States High Potency API Sales Volume Forecast by Type (2017-2022)
11.3 United States High Potency API Sales Volume Forecast by Application (2017-2022)
11.4 United States High Potency API Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of High Potency API
Figure United States High Potency API Market Size (MT) by Type (2012-2022)
Figure United States High Potency API Sales Volume Market Share by Type (Product Category) in 2016
Figure Synthetic HPAPIs Product Picture
Figure Biotech HPAPIs Product Picture
Figure United States High Potency API Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of High Potency API by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Hormonal Disorders Examples
Table Key Downstream Customer in Hormonal Disorders
Figure Glaucoma Examples
Table Key Downstream Customer in Glaucoma
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States High Potency API Market Size (Million USD) by Region (2012-2022)
Figure The West High Potency API Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest High Potency API Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic High Potency API Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England High Potency API Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US High Potency API Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest High Potency API Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States High Potency API Sales (MT) and Growth Rate (2012-2022)
Figure United States High Potency API Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States High Potency API Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States High Potency API Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States High Potency API Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States High Potency API Sales Share by Players/Suppliers
Figure 2017 United States High Potency API Sales Share by Players/Suppliers
Figure United States High Potency API Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States High Potency API Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States High Potency API Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States High Potency API Revenue Share by Players/Suppliers
Figure 2017 United States High Potency API Revenue Share by Players/Suppliers
Table United States Market High Potency API Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market High Potency API Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States High Potency API Market Share of Top 3 Players/Suppliers
Figure United States High Potency API Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers High Potency API Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers High Potency API Product Category
Table United States High Potency API Sales (MT) by Region (2012-2017)
Table United States High Potency API Sales Share by Region (2012-2017)
Figure United States High Potency API Sales Share by Region (2012-2017)
Figure United States High Potency API Sales Market Share by Region in 2016
Table United States High Potency API Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States High Potency API Revenue Share by Region (2012-2017)
Figure United States High Potency API Revenue Market Share by Region (2012-2017)
Figure United States High Potency API Revenue Market Share by Region in 2016
Table United States High Potency API Price (USD/Kg) by Region (2012-2017)
Table United States High Potency API Sales (MT) by Type (2012-2017)
Table United States High Potency API Sales Share by Type (2012-2017)
Figure United States High Potency API Sales Share by Type (2012-2017)
Figure United States High Potency API Sales Market Share by Type in 2016
Table United States High Potency API Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States High Potency API Revenue Share by Type (2012-2017)
Figure Revenue Market Share of High Potency API by Type (2012-2017)
Figure Revenue Market Share of High Potency API by Type in 2016
Table United States High Potency API Price (USD/Kg) by Types (2012-2017)
Figure United States High Potency API Sales Growth Rate by Type (2012-2017)
Table United States High Potency API Sales (MT) by Application (2012-2017)
Table United States High Potency API Sales Market Share by Application (2012-2017)
Figure United States High Potency API Sales Market Share by Application (2012-2017)
Figure United States High Potency API Sales Market Share by Application in 2016
Table United States High Potency API Sales Growth Rate by Application (2012-2017)
Figure United States High Potency API Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer High Potency API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer High Potency API Sales Growth Rate (2012-2017)
Figure Pfizer High Potency API Sales Market Share in United States (2012-2017)
Figure Pfizer High Potency API Revenue Market Share in United States (2012-2017)
Table Novartis International Basic Information List
Table Novartis International High Potency API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis International High Potency API Sales Growth Rate (2012-2017)
Figure Novartis International High Potency API Sales Market Share in United States (2012-2017)
Figure Novartis International High Potency API Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi High Potency API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi High Potency API Sales Growth Rate (2012-2017)
Figure Sanofi High Potency API Sales Market Share in United States (2012-2017)
Figure Sanofi High Potency API Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim High Potency API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim High Potency API Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim High Potency API Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim High Potency API Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb High Potency API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb High Potency API Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb High Potency API Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb High Potency API Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical High Potency API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical High Potency API Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical High Potency API Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical High Potency API Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company High Potency API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly and Company High Potency API Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company High Potency API Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company High Potency API Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline High Potency API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline High Potency API Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline High Potency API Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline High Potency API Revenue Market Share in United States (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co High Potency API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck & Co High Potency API Sales Growth Rate (2012-2017)
Figure Merck & Co High Potency API Sales Market Share in United States (2012-2017)
Figure Merck & Co High Potency API Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie High Potency API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbbVie High Potency API Sales Growth Rate (2012-2017)
Figure AbbVie High Potency API Sales Market Share in United States (2012-2017)
Figure AbbVie High Potency API Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Bayer Basic Information List
Table Mylan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of High Potency API
Figure Manufacturing Process Analysis of High Potency API
Figure High Potency API Industrial Chain Analysis
Table Raw Materials Sources of High Potency API Major Players/Suppliers in 2016
Table Major Buyers of High Potency API
Table Distributors/Traders List
Figure United States High Potency API Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States High Potency API Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States High Potency API Price (USD/Kg) Trend Forecast (2017-2022)
Table United States High Potency API Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States High Potency API Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States High Potency API Sales Volume (MT) Forecast by Type in 2022
Table United States High Potency API Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States High Potency API Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States High Potency API Sales Volume (MT) Forecast by Application in 2022
Table United States High Potency API Sales Volume (MT) Forecast by Region (2017-2022)
Table United States High Potency API Sales Volume Share Forecast by Region (2017-2022)
Figure United States High Potency API Sales Volume Share Forecast by Region (2017-2022)
Figure United States High Potency API Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources